Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Schütz F[au]:

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. Motzer RJ et al. N Engl J Med. (2015)

PD-1/PD-L1 Pathway in Breast Cancer. Schütz F et al. Oncol Res Treat. (2017)

Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients. De Velasco G et al. Cancer Immunol Res. (2017)

Search results

Items: 1 to 50 of 152

1.

Tissue- and sex-specific small RNAomes reveal sex differences in response to the environment.

Bezler A, Braukmann F, West SM, Duplan A, Conconi R, Schütz F, Gönczy P, Piano F, Gunsalus K, Miska EA, Keller L.

PLoS Genet. 2019 Feb 8;15(2):e1007905. doi: 10.1371/journal.pgen.1007905. [Epub ahead of print]

2.

Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.

Michel LL, Sommer L, González Silos R, Lorenzo Bermejo J, von Au A, Seitz J, Hennigs A, Smetanay K, Golatta M, Heil J, Schütz F, Sohn C, Schneeweiss A, Marmé F.

PLoS One. 2019 Jan 31;14(1):e0211337. doi: 10.1371/journal.pone.0211337. eCollection 2019.

3.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.

Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, Jírů-Hillmann S, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Baumgartner T, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching P, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Buck A, Stangl S.

Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1056-1088. doi: 10.1055/a-0646-4630. Epub 2018 Nov 26.

4.

ABPS: An R Package for Calculating the Abnormal Blood Profile Score.

Schütz F, Zollinger A.

Front Physiol. 2018 Nov 21;9:1638. doi: 10.3389/fphys.2018.01638. eCollection 2018.

5.

Update Breast Cancer 2018 (Part 4) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer.

Müller V, Wöckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Hadji P, Tesch H, Ettl J, Lüftner D, Welslau M, Belleville E, Brucker SY, Schütz F, Fasching PA, Fehm TN, Kolberg HC, Schneeweiss A, Overkamp F.

Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1119-1128. doi: 10.1055/a-0715-2899. Epub 2018 Nov 26.

6.

Update Breast Cancer 2018 (Part 3) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer.

Wöckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Hadji P, Tesch H, Ettl J, Lüftner D, Müller V, Welslau M, Belleville E, Brucker SY, Schütz F, Fasching PA, Fehm TN, Schneeweiss A, Kolberg HC.

Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1110-1118. doi: 10.1055/a-0715-2821. Epub 2018 Nov 26.

7.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer.

Wöckel A, Festl J, Stüber T, Brust K, Stangl S, Heuschmann PU, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching PA, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Krockenberger M.

Geburtshilfe Frauenheilkd. 2018 Oct;78(10):927-948. doi: 10.1055/a-0646-4522. Epub 2018 Oct 19.

8.

Worldwide distribution of blood values in elite track and field athletes: Biomarkers of altered erythropoiesis.

Robinson N, Saugy J, Schütz F, Faiss R, Baume N, Giraud S, Saugy M.

Drug Test Anal. 2018 Oct 22. doi: 10.1002/dta.2526. [Epub ahead of print]

PMID:
30345707
9.

Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer.

Jauch SF, Riethdorf S, Sprick MR, Schütz F, Schönfisch B, Brucker SY, Deutsch TM, Nees J, Saini M, Becker LM, Burwinkel B, Sinn P, Marmé F, Pantel K, Jäger D, Sohn C, Trumpp A, Wallwiener M, Schneeweiss A.

Breast Cancer Res Treat. 2018 Oct 1. doi: 10.1007/s10549-018-4972-y. [Epub ahead of print]

PMID:
30276763
10.

RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment.

Hellweg R, Mooneyham A, Chang Z, Shetty M, Emmings E, Iizuka Y, Clark C, Starr T, Abrahante JH, Schütz F, Konecny G, Argenta P, Bazzaro M.

Horm Cancer. 2018 Oct;9(5):326-337. doi: 10.1007/s12672-018-0337-6. Epub 2018 Jun 27.

PMID:
29951943
11.

Immunooncology in Breast Cancer: Active and Passive Vaccination Strategies.

Schütz F, Marmé F, Domschke C, Sohn C, von Au A.

Breast Care (Basel). 2018 Mar;13(1):22-26. doi: 10.1159/000486330. Epub 2018 Jan 31. Review.

12.

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma.

McKay RR, Bossé D, Xie W, Wankowicz SAM, Flaifel A, Brandao R, Lalani AA, Martini DJ, Wei XX, Braun DA, Van Allen E, Castellano D, De Velasco G, Wells JC, Heng DY, Fay AP, Schutz FA, Hsu J, Pal SK, Lee JL, Hsieh JJ, Harshman LC, Signoretti S, Motzer RJ, Feldman D, Choueiri TK.

Cancer Immunol Res. 2018 Jul;6(7):758-765. doi: 10.1158/2326-6066.CIR-17-0475. Epub 2018 May 10.

PMID:
29748390
13.

Positron Emission Tomography (PET) and PET/CT in Thyroid Cancer: A Systematic Review and Meta-Analysis.

Schütz F, Lautenschläger C, Lorenz K, Haerting J.

Eur Thyroid J. 2018 Jan;7(1):13-20. doi: 10.1159/000481707. Epub 2017 Oct 24.

14.

Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.

Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Schütz F, Fasching PA, Fehm TN.

Geburtshilfe Frauenheilkd. 2018 Mar;78(3):246-259. doi: 10.1055/s-0044-101614. Epub 2018 Mar 21.

15.

Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers.

Taran FA, Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Fasching PA, Fehm TN, Schütz F.

Geburtshilfe Frauenheilkd. 2018 Mar;78(3):237-245. doi: 10.1055/s-0044-101613. Epub 2018 Mar 21.

16.

Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective.

Sade JP, Báez CAV, Greco M, Martínez CH, Avitia MÁÁ, Palazzo C, Toriz NH, Trujillo PIB, Bastos DA, Schutz FA, Bella S, Nogueira L, Shore ND.

Med Oncol. 2018 Mar 19;35(4):56. doi: 10.1007/s12032-018-1105-8. Review.

17.

Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events.

Martini DJ, Hamieh L, McKay RR, Harshman LC, Brandao R, Norton CK, Steinharter JA, Krajewski KM, Gao X, Schutz FA, McGregor B, Bossé D, Lalani AA, De Velasco G, Michaelson MD, McDermott DF, Choueiri TK.

Cancer Immunol Res. 2018 Apr;6(4):402-408. doi: 10.1158/2326-6066.CIR-17-0220. Epub 2018 Feb 1.

PMID:
29437040
18.

Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis.

Schaefgen B, Heil J, Barr RG, Radicke M, Harcos A, Gomez C, Stieber A, Hennigs A, von Au A, Spratte J, Rauch G, Rom J, Schütz F, Sohn C, Golatta M.

Eur Radiol. 2018 Jun;28(6):2499-2506. doi: 10.1007/s00330-017-5235-8. Epub 2018 Jan 4.

PMID:
29302784
19.

Severe Fournier's gangrene-a conjoint challenge of gynaecology and plastic surgery.

Wähmann M, Wähmann M, Schütz F, Sohn C, Schott S, Kremer T, Hernekamp JF, Kneser U.

J Surg Case Rep. 2017 Dec 8;2017(12):rjx239. doi: 10.1093/jscr/rjx239. eCollection 2017 Dec.

20.

Low number of fixed somatic mutations in a long-lived oak tree.

Schmid-Siegert E, Sarkar N, Iseli C, Calderon S, Gouhier-Darimont C, Chrast J, Cattaneo P, Schütz F, Farinelli L, Pagni M, Schneider M, Voumard J, Jaboyedoff M, Fankhauser C, Hardtke CS, Keller L, Pannell JR, Reymond A, Robinson-Rechavi M, Xenarios I, Reymond P.

Nat Plants. 2017 Dec;3(12):926-929. doi: 10.1038/s41477-017-0066-9. Epub 2017 Dec 4.

PMID:
29209081
21.

Stimulation of chemokines in human endometrial stromal cells by tumor necrosis factor-α and interferon-γ is similar under apoptotic and non-apoptotic conditions.

Spratte J, Princk H, Schütz F, Rom J, Zygmunt M, Fluhr H.

Arch Gynecol Obstet. 2018 Feb;297(2):505-512. doi: 10.1007/s00404-017-4586-3. Epub 2017 Nov 21.

PMID:
29164336
22.

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.

Moreira RB, Debiasi M, Francini E, Nuzzo PV, Velasco G, Maluf FC, Fay AP, Bellmunt J, Choueiri TK, Schutz FA.

Oncotarget. 2017 Aug 8;8(48):84572-84578. doi: 10.18632/oncotarget.20028. eCollection 2017 Oct 13. Review.

23.

The EIGER detector for low-energy electron microscopy and photoemission electron microscopy.

Tinti G, Marchetto H, Vaz CAF, Kleibert A, Andrä M, Barten R, Bergamaschi A, Brückner M, Cartier S, Dinapoli R, Franz T, Fröjdh E, Greiffenberg D, Lopez-Cuenca C, Mezza D, Mozzanica A, Nolting F, Ramilli M, Redford S, Ruat M, Ruder C, Schädler L, Schmidt T, Schmitt B, Schütz F, Shi X, Thattil D, Vetter S, Zhang J.

J Synchrotron Radiat. 2017 Sep 1;24(Pt 5):963-974. doi: 10.1107/S1600577517009109. Epub 2017 Aug 9.

PMID:
28862618
24.

Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey.

Klein E, Beckmann MW, Bader W, Brucker C, Dobos G, Fischer D, Hanf V, Hasenburg A, Jud SM, Kalder M, Kiechle M, Kümmel S, Müller A, Müller MT, Paepke D, Rotmann AR, Schütz F, Scharl A, Voiss P, Wallwiener M, Witt C, Hack CC.

Arch Gynecol Obstet. 2017 Aug;296(2):295-301. doi: 10.1007/s00404-017-4420-y. Epub 2017 Jun 8.

25.

Association between the use of magnesium sulfate as neuroprotector in prematurity and the neonatal hemodynamic effects.

Nunes RD, Schutz FD, Traebert JL.

J Matern Fetal Neonatal Med. 2018 Jul;31(14):1900-1905. doi: 10.1080/14767058.2017.1332033. Epub 2017 Jun 2.

PMID:
28521581
26.

The functional muscle-bone unit in children with cerebral palsy.

Duran I, Schütz F, Hamacher S, Semler O, Stark C, Schulze J, Rittweger J, Schoenau E.

Osteoporos Int. 2017 Jul;28(7):2081-2093. doi: 10.1007/s00198-017-4023-2. Epub 2017 Apr 1.

PMID:
28365851
27.

UNC-45A is required for neurite extension via controlling NMII activation.

Iizuka Y, Mooneyham A, Sieben A, Chen K, Maile M, Hellweg R, Schütz F, Teckle K, Starr T, Thayanithy V, Vogel RI, Lou E, Lee MK, Bazzaro M.

Mol Biol Cell. 2017 May 15;28(10):1337-1346. doi: 10.1091/mbc.E16-06-0381. Epub 2017 Mar 29.

28.

PD-1/PD-L1 Pathway in Breast Cancer.

Schütz F, Stefanovic S, Mayer L, von Au A, Domschke C, Sohn C.

Oncol Res Treat. 2017;40(5):294-297. doi: 10.1159/000464353. Epub 2017 Mar 27. Review.

29.

Diurnal regulation of RNA polymerase III transcription is under the control of both the feeding-fasting response and the circadian clock.

Mange F, Praz V, Migliavacca E, Willis IM, Schütz F, Hernandez N; CycliX Consortium.

Genome Res. 2017 Jun;27(6):973-984. doi: 10.1101/gr.217521.116. Epub 2017 Mar 24.

30.

Metronomic Chemotherapy for Primary Non-Metastatic Breast Cancer - a Systematic Review of the Literature.

Banys-Paluchowski M, Ruckhäberle E, Schütz F, Krawczyk N, Fehm T.

Geburtshilfe Frauenheilkd. 2017 Feb;77(2):142-148. doi: 10.1055/s-0043-100388.

31.

Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients.

De Velasco G, Je Y, Bossé D, Awad MM, Ott PA, Moreira RB, Schutz F, Bellmunt J, Sonpavde GP, Hodi FS, Choueiri TK.

Cancer Immunol Res. 2017 Apr;5(4):312-318. doi: 10.1158/2326-6066.CIR-16-0237. Epub 2017 Feb 28. Erratum in: Cancer Immunol Res. 2018 Apr;6(4):498-499.

32.

First Brazilian Consensus of Advanced Prostate Cancer: Recommendations for Clinical Practice.

Sasse AD, Wiermann EG, Herchenhorn D, Bastos DA, Schutz FA, Maluf FC, Coura G Filho, Morbeck IAP, Cerci JJ, Smaletz O, Lima VS, Adamy A Jr, Campos FS, Carvalhal GF, Cezar LC, Dall'Oglio MF, Sadi MV, Reis RBD, Nogueira L.

Int Braz J Urol. 2017 May-Jun;43(3):407-415. doi: 10.1590/S1677-5538.IBJU.2016.0490.

33.

Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer.

Deutsch TM, Riethdorf S, Nees J, Hartkopf AD, Schönfisch B, Domschke C, Sprick MR, Schütz F, Brucker SY, Stefanovic S, Sohn C, Pantel K, Trumpp A, Schneeweiss A, Wallwiener M.

Breast Cancer Res Treat. 2016 Nov;160(2):277-290. Epub 2016 Oct 1.

PMID:
27696083
34.

Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.

Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marmé F, Jäger D, Kauczor HU, Stieber A, Lindel K, Debus J, Golatta M, Schütz F, Sohn C, Heil J, Schneeweiss A.

BMC Cancer. 2016 Sep 15;16(1):734. doi: 10.1186/s12885-016-2766-3.

35.

Identification of a novel PPARβ/δ/miR-21-3p axis in UV-induced skin inflammation.

Degueurce G, D'Errico I, Pich C, Ibberson M, Schütz F, Montagner A, Sgandurra M, Mury L, Jafari P, Boda A, Meunier J, Rezzonico R, Brembilla NC, Hohl D, Kolios A, Hofbauer G, Xenarios I, Michalik L.

EMBO Mol Med. 2016 Aug 1;8(8):919-36. doi: 10.15252/emmm.201505384. Print 2016 Aug.

36.

Immunological Mechanisms in Breast Cancer - from Bench to Bedside.

Denkert C, Schütz F.

Breast Care (Basel). 2016 Apr;11(2):93-4. doi: 10.1159/000446266. Epub 2016 Apr 27. No abstract available.

37.

Metronomic Chemotherapy for Metastatic Breast Cancer - a Systematic Review of the Literature.

Banys-Paluchowski M, Schütz F, Ruckhäberle E, Krawczyk N, Fehm T.

Geburtshilfe Frauenheilkd. 2016 May;76(5):525-534. Review.

38.

LECANDUS study (LEsion CANdidate Detection in UltraSound Data): evaluation of image analysis algorithms for breast lesion detection in volume ultrasound data.

Golatta M, Zeegers D, Filippatos K, Binder LL, Scharf A, Rauch G, Rom J, Schütz F, Sohn C, Heil J.

Arch Gynecol Obstet. 2016 Aug;294(2):423-8. doi: 10.1007/s00404-016-4127-5. Epub 2016 May 28.

PMID:
27236704
39.

Unfractionated Heparin Selectively Modulates the Expression of CXCL8, CCL2 and CCL5 in Endometrial Carcinoma Cells.

Doster A, Schwarzig U, Zygmunt M, Rom J, Schütz F, Fluhr H.

Anticancer Res. 2016 Apr;36(4):1535-44.

PMID:
27069129
40.

Targeted Therapy of HER2-Negative Breast Cancer.

Schütz F, Domschke C, Schneeweiss A.

Oncol Res Treat. 2016;39(3):118-21. doi: 10.1159/000444204. Epub 2016 Feb 10. Review.

41.

The presence of heparins during decidualization modulates the response of human endometrial stromal cells to IL-1β in vitro.

Spratte J, Bornkessel F, Schütz F, Zygmunt M, Fluhr H.

J Assist Reprod Genet. 2016 Jul;33(7):949-57. doi: 10.1007/s10815-016-0703-7. Epub 2016 Mar 24.

42.

A Review of Integrative Medicine in Gynaecological Oncology.

Kalder M, Müller T, Fischer D, Müller A, Bader W, Beckmann MW, Brucker C, Hack CC, Hanf V, Hasenburg A, Hein A, Jud S, Kiechle M, Klein E, Paepke D, Rotmann A, Schütz F, Dobos G, Voiß P, Kümmel S.

Geburtshilfe Frauenheilkd. 2016 Feb;76(2):150-155. Review.

43.

Validation of the Mass-Extraction-Window for Quantitative Methods Using Liquid Chromatography High Resolution Mass Spectrometry.

Glauser G, Grund B, Gassner AL, Menin L, Henry H, Bromirski M, Schütz F, McMullen J, Rochat B.

Anal Chem. 2016 Mar 15;88(6):3264-71. doi: 10.1021/acs.analchem.5b04689. Epub 2016 Feb 23.

PMID:
26836506
44.

Increased diversity of egg-associated bacteria on brown trout (Salmo trutta) at elevated temperatures.

Wilkins LG, Rogivue A, Schütz F, Fumagalli L, Wedekind C.

Sci Rep. 2015 Nov 27;5:17084. doi: 10.1038/srep17084.

45.

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2015.

Hanf V, Schütz F, Liedtke C, Thill M; AGO Breast Committee.

Breast Care (Basel). 2015 Jul;10(3):189-97. doi: 10.1159/000431346. Epub 2015 Jun 18. No abstract available.

46.

Change of Patient-Reported Aesthetic Outcome Over Time and Identification of Factors Characterizing Poor Aesthetic Outcome After Breast-Conserving Therapy: Long-Term Results of a Prospective Cohort Study.

Hennigs A, Biehl H, Rauch G, Golatta M, Tabatabai P, Domschke C, Schott S, Wallwiener M, Schütz F, Sohn C, Heil J.

Ann Surg Oncol. 2016 May;23(5):1744-51. doi: 10.1245/s10434-015-4943-z. Epub 2015 Nov 6.

PMID:
26545376
47.

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.

Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, Castellano D, Choueiri TK, Gurney H, Donskov F, Bono P, Wagstaff J, Gauler TC, Ueda T, Tomita Y, Schutz FA, Kollmannsberger C, Larkin J, Ravaud A, Simon JS, Xu LA, Waxman IM, Sharma P; CheckMate 025 Investigators.

N Engl J Med. 2015 Nov 5;373(19):1803-13. doi: 10.1056/NEJMoa1510665. Epub 2015 Sep 25.

48.

The Prevention of Positioning Injuries during Gynecologic Operations. Guideline of DGGG (S1-Level, AWMF Registry No. 015/077, February 2015).

Fleisch MC, Bremerich D, Schulte-Mattler W, Tannen A, Teichmann AT, Bader W, Balzer K, Renner SP, Römer T, Roth S, Schütz F, Thill M, Tinneberg H, Zarras K.

Geburtshilfe Frauenheilkd. 2015 Aug;75(8):792-807.

49.

Long-term objective esthetic outcome after breast-conserving therapy.

Hennigs A, Hartmann B, Rauch G, Golatta M, Tabatabai P, Domschke C, Schott S, Schütz F, Sohn C, Heil J.

Breast Cancer Res Treat. 2015 Sep;153(2):345-51. doi: 10.1007/s10549-015-3540-y. Epub 2015 Aug 13.

PMID:
26267662
50.

Aromatase Inhibitors in the Prevention of Breast Cancer.

Stickeler E, Fehm T, Schütz F, Thill M.

Breast Care (Basel). 2015 Apr;10(2):141-2. doi: 10.1159/000430877. No abstract available.

Supplemental Content

Loading ...
Support Center